Skip to content
Homepage
Author:
HISTOINDEX PTE. LTD
Posted Date:
June 17, 2026
AI-Powered Analysis by HistoIndex Reveals Robust Liver Fibrosis Improvement with D&D Pharmatech’s Zabopegdutide in Phase 2 MASH Trial
HISTOINDEX PTE. LTD
June 17, 2026
HistoIndex Extends Access To Its MASH Diagnostic Offering Through New Partnerships In Texas And California
HISTOINDEX PTE. LTD
April 28, 2026
